Literature DB >> 25394442

Post-partum acute kidney injury.

Naresh Pahwa, Rajesh Bharani1, Ravindra Kumar.   

Abstract

To determine the risk factors, course of hospital stay and mortality rate among women with post-partum acute kidney injury (AKI), we studied (of 752 patients with AKI admitted to a tertiary care center during the study period between November 2009 and August 2012) 27 (3.59%) women with post-partum AKI. The data regarding age, parity, cause of renal failure, course of hospital stay and requirement of dialysis were recorded. Sepsis was the major cause (70.3%) of post-partum AKI. Other causes included disseminated intravascular coagulation (55.5%), pre-eclampsia/eclampsia (40.7%), ante- and post-partum hemorrhage (40.7% and 22.2%) and hemolytic anemia and elevated liver enzymes and low platelet count syndrome (29.6%); most patients had more than one cause of AKI. We found a very high prevalence (18.5%) of cortical necrosis in our study patients. A significant correlation was also found between the creatinine level on admission and the period of onset of disease after delivery. In conclusion, several factors are involved in causing post-partum AKI in our population, and sepsis was the most common of them.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25394442     DOI: 10.4103/1319-2442.144259

Source DB:  PubMed          Journal:  Saudi J Kidney Dis Transpl        ISSN: 1319-2442


  3 in total

1.  Postpartum Acute Kidney Injury: Experience of a Tertiary Care Center.

Authors:  M M Mir; M S Najar; A M Chaudary; H Azad; A R Reshi; K A Banday; M A Bhat; I A Wani; M M Wani; M Ursilla
Journal:  Indian J Nephrol       Date:  2017 May-Jun

2.  Pregnancy-related acute kidney injury: An analysis of 165 cases.

Authors:  E Mahesh; S Puri; V Varma; P R Madhyastha; S Bande; K C Gurudev
Journal:  Indian J Nephrol       Date:  2017 Mar-Apr

3.  Diagnostic Value of Urinary Microalbumin Level in Postpartum Acute Kidney Injury.

Authors:  Jian Zhang; Ning Li; Wenling Guo; Chuanyan Ma; Guangcheng Zhao
Journal:  Iran J Public Health       Date:  2018-03       Impact factor: 1.429

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.